Literature DB >> 22147606

Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma.

J Humberto Treviño-Villarreal1, Douglas A Cotanche, Rosalinda Sepúlveda, Magda E Bortoni, Otto Manneberg, Taturo Udagawa, Rick A Rogers.   

Abstract

Identification of cell types in tumor-associated stroma that are involved in the development of melanoma is hampered by their heterogeneity. The authors used flow cytometry and immunohistochemistry to demonstrate that anti-MART-1 antibodies can discriminate between melanoma and stroma cells. They investigated the cellular composition of the MART-1-, non-hematopoietic melanoma-associated stroma, finding it consisted mainly of Sca-1+ and CD146+ cells. These cell types were also observed in the skin and muscle adjacent to developing melanomas. The Sca-1+ cell population was observed distributed in the epidermis, hair follicle bulges, and tumor capsule. The CD146+ population was found distributed within the tumor, mainly associated with blood vessels in a perivascular location. In addition to a perivascular distribution, CD146+ cells expressed α-smooth muscle actin, lacked expression of endothelial markers CD31 and CD34, and were therefore identified as pericytes. Pericytes were found to be associated with CD31+ endothelial cells; however, some pericytes were also observed associated with CD31-, MART-1+ B16 melanoma cells that appeared to form blood vessel structures. Furthermore, the authors observed extensive nuclear expression of HIF-1α in melanoma and stroma cells, suggesting hypoxia is an important factor associated with the melanoma microenvironment and vascularization. The results suggest that pericytes and Sca-1+ stroma cells are important contributors to melanoma development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22147606      PMCID: PMC3283083          DOI: 10.1369/0022155411428078

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  57 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Tumor-host interactions: a far-reaching relationship.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 3.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

4.  Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.

Authors:  V B Shidham; D Y Qi; S Acker; B Kampalath; C C Chang; V George; R Komorowski
Journal:  Am J Surg Pathol       Date:  2001-08       Impact factor: 6.394

5.  VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

Authors:  Natasha Y Frank; Tobias Schatton; Soo Kim; Qian Zhan; Brian J Wilson; Jie Ma; Karim R Saab; Veronika Osherov; Hans R Widlund; Martin Gasser; Ana-Maria Waaga-Gasser; Thomas S Kupper; George F Murphy; Markus H Frank
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

Review 6.  Cells of origin in cancer.

Authors:  Jane E Visvader
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 7.  Tumor-stromal cell interactions and opportunities for therapeutic intervention.

Authors:  Taturo Udagawa; Mark Wood
Journal:  Curr Opin Pharmacol       Date:  2010-07-16       Impact factor: 5.547

8.  Stromal vascular progenitors in adult human adipose tissue.

Authors:  Ludovic Zimmerlin; Vera S Donnenberg; Melanie E Pfeifer; E Michael Meyer; Bruno Péault; J Peter Rubin; Albert D Donnenberg
Journal:  Cytometry A       Date:  2010-01       Impact factor: 4.355

9.  Direct and indirect contribution of bone marrow-derived cells to cancer.

Authors:  Ian Guest; Zoran Ilic; Jun Ma; Denise Grant; Gennadi Glinsky; Stewart Sell
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

10.  Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth.

Authors:  Veronica R Placencio; Xiaohong Li; Taylor P Sherrill; Gloria Fritz; Neil A Bhowmick
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more
  6 in total

1.  Establishment of in vitro culture system for evaluating dentin-pulp complex regeneration with special reference to the differentiation capacity of BrdU label-retaining dental pulp cells.

Authors:  Hiroko Ida-Yonemochi; Mitsushiro Nakatomi; Hayato Ohshima
Journal:  Histochem Cell Biol       Date:  2014-02-23       Impact factor: 4.304

2.  DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature.

Authors:  Nina Chi Sabins; Jennifer L Taylor; Kellsye P L Fabian; Leonard J Appleman; Jodi K Maranchie; Donna Beer Stolz; Walter J Storkus
Journal:  Mol Ther       Date:  2013-07-30       Impact factor: 11.454

3.  Genetic Polymorphisms Associated with Hearing Threshold Shift in Subjects during First Encounter with Occupational Impulse Noise.

Authors:  Yohann Grondin; Magda E Bortoni; Rosalinda Sepulveda; Elisa Ghelfi; Adam Bartos; Douglas Cotanche; Royce E Clifford; Rick A Rogers
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

4.  Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2013-01-10       Impact factor: 5.310

Review 5.  Putative role of HIF transcriptional activity in melanocytes and melanoma biology.

Authors:  Blazej Zbytek; Danielle L Peacock; Tiffany N Seagroves; Andrzej Slominski
Journal:  Dermatoendocrinol       Date:  2013-04-01

6.  Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.

Authors:  Mark Duquette; Peter M Sadow; Jack Lawler; Carmelo Nucera
Journal:  Front Endocrinol (Lausanne)       Date:  2013-12-02       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.